Tech Company Financing Transactions

Actimed Therapeutics Funding Round

On 6/26/2023, Actimed Therapeutics raised $6.3 million in Series A funding from Mankind Pharma.

Transaction Overview

Announced On
6/26/2023
Transaction Type
Venture Equity
Amount
$6,320,000
Round
Series A
Investors

Mankind Pharma (Lead Investor)

Proceeds Purpose
The company intends to use the funds to support the development of its pipeline, including S-pindolol benzoate, with preparations under way for a Phase 2b/3 programme (the "IMPACT" programme) targeted at the treatment of cancer cachexia in non-small cell lung cancer and colorectal cancer.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
The Old Bakehouse, Course Road, Ascot
Berkshire, SL5 7HL
UK
Phone
Undisclosed
Email Address
Overview
We are focused on bringing innovation to the treatment of cachexia with a vision to transform care for an under-served and vulnerable patient population, prolong and improve the quality of their lives, restore their dignity and ease the burden for the patient, carer and provider. Cachexia is a wasting disease that accompanies cancer and other serious chronic illnesses and is associated with significant morbidity and mortality. Despite its prevalence and devastating clinical effects, there is no globally approved pharmaceutical product for the treatment or prevention of cancer-related cachexia.
Profile
Actimed Therapeutics LinkedIn Company Profile
Social Media
Actimed Therapeutics Company Twitter Account
Company News
Actimed Therapeutics News
Facebook
Actimed Therapeutics on Facebook
YouTube
Actimed Therapeutics on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Robin Bhattacherjee
  Robin Bhattacherjee LinkedIn Profile  Robin Bhattacherjee Twitter Account  Robin Bhattacherjee News  Robin Bhattacherjee on Facebook
Chief Medical Officer
Frank Misselwitz
  Frank Misselwitz LinkedIn Profile  Frank Misselwitz Twitter Account  Frank Misselwitz News  Frank Misselwitz on Facebook


 

 

Browse more venture capital transactions:

Prev: 6/26/2023: Crux venture capital transaction
Next: 6/26/2023: Metatime venture capital transaction

 

Share this article

 


Where The Data Comes From

We do our best to record funding rounds that are announced publicly. VC investment data records reported here are sourced from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary